Coeptis Therapeutics Holdings, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
  • Coeptis Therapeutics Holdings, Inc. Current Ratio for the quarter ending June 30, 2024 was 51.3 %, a 51.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 51.3 -54.2 -51.4% Jun 30, 2024
Q1 2024 68 -17.7 -20.7% Mar 31, 2024
Q4 2023 88.4 +8.22 +10.3% Dec 31, 2023
Q3 2023 118 +75.2 +176% Sep 30, 2023
Q2 2023 105 +29.7 +39.3% Jun 30, 2023
Q1 2023 85.7 -29.3 -25.5% Mar 31, 2023
Q4 2022 80.2 -69.9 -46.6% Dec 31, 2022
Q3 2022 42.7 -2.59K -98.4% Sep 30, 2022
Q2 2022 75.7 Jun 30, 2022
Q1 2022 115 Mar 31, 2022
Q4 2021 150 Dec 31, 2021
Q3 2021 2.63K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.